The Biochemistry of Kambo — What This Secretion Is Actually Doing Inside Your Body

The word detox has followed Kambo into the wellness mainstream like an uninvited guest. It features in retreat descriptions, in Instagram captions, in the first thing people say when they're trying to explain it to someone who's never heard of it. It has intuitive appeal. It is also, biochemically speaking, an oversimplification so significant it does the medicine a disservice.

Kambo does not "flush toxins." It does not "cleanse" in the passive, dietary-supplement sense of that word. What it does is engage the human body through a highly specific molecular mechanism — a lock-and-key interaction between its bioactive peptides and precise receptor sites across multiple organ systems. That mechanism produces dramatic, time-limited effects, and understanding it changes how you prepare for, experience, and integrate this medicine.

So let's talk about what the science actually shows.

The Frog and Its Secretion

Phyllomedusa bicolor — the giant monkey frog of the western and central Amazon — produces a skin secretion unlike anything else in nature. The secretion is not venom (which is actively injected) and, in the pharmacological sense, not a toxin (which damages cells). It is a bioactive peptide secretion: a precisely evolved cocktail of molecular messengers designed to interact with the nervous systems of other organisms.

Across the entire Phyllomedusa genus, more than 277 unique peptide sequences have been characterized since the first isolation in 1966.¹ In P. bicolor specifically, 28 distinct peptide sequences have been identified.² Bioactive peptides make up approximately 7.5% of the secretion by dry weight — meaning a standard dose of three to five gates (each gate approximately 10mg of secretion) delivers a total of roughly 30–50mg of active peptide material into the lymphatic system through the burned skin.³

That material contains, per gate: roughly 320 micrograms of phyllocaerulein, 220 micrograms of phyllomedusin, 180 micrograms of phyllokinin, 53 micrograms of deltorphin, 30 micrograms of sauvagine, and trace amounts of dermorphin and dermaseptins.⁴ Each of these acts on different receptor types, through different pathways, producing the recognizable constellation of Kambo's effects.

Phyllomedusin — The Cardiovascular Opener

Phyllomedusin is a tachykinin peptide — meaning it belongs to the same family as substance P and neurokinin A, compounds the human nervous system uses to regulate smooth muscle tone, secretion, and vascular function. It acts as a potent agonist at the neurokinin-1 (NK1) receptor, producing rapid vasodilation: the widening of blood vessels that causes the characteristic heat, flushing, and accelerated heartbeat within the first 60 seconds of a ceremony.

As blood vessels dilate, pressure drops temporarily and the heart compensates with reflex tachycardia. The medicine is carried rapidly through the circulatory system. This is not a side effect — it is the delivery mechanism. Phyllomedusin also stimulates salivary and lacrimal gland secretion, contributing to the tears and mucus commonly produced during the session.

Interestingly, P. bicolor itself lacks the NK1 receptors that phyllomedusin acts upon.⁵ The frog evolved a peptide specifically designed to act on other organisms' biology — a precise evolutionary adaptation with no apparent effect on its own tissue.

Phyllocaerulein — The Architecture of the Purge

The purge — the aspect of Kambo most often mischaracterized as "expelling toxins" — is not random or chaotic. It is mechanically produced by phyllocaerulein, which acts primarily on cholecystokinin-A (CCK-A) receptors in the gastrointestinal system. Activation of these receptors triggers contraction of the gallbladder, stimulates the secretion of gastric and pancreatic enzymes, and initiates coordinated smooth muscle contractions along the GI tract.

The result is a rapid, physiologically orchestrated clearing of the digestive system — not the body rejecting a poison, but a peptide delivering a specific signal to a specific receptor class with a predictable, purposeful outcome.⁶ Phyllocaerulein is structurally nearly identical to caerulein, a compound used in clinical pharmacology and researched as an adjunct in schizophrenia treatment — the biochemical similarity is so close that distinguishing the two analytically in a given Kambo sample is genuinely difficult.⁷

Holistika Center Retreats

Sauvagine — The Stress Hormone Cascade

Sauvagine is a 40-amino acid peptide that acts on corticotropin-releasing factor type 1 (CRF1) receptors — the same receptors targeted by the brain's own stress-signaling molecule, CRH (corticotropin-releasing hormone). Activation of CRF1 receptors engages the hypothalamic-pituitary-adrenal (HPA) axis, triggering a cascade that includes cortisol release, sympathetic nervous system activation, and increased sensory perception.

This is the pharmacological basis for the intense, acute stress experience at the peak of a Kambo session — a rapid, forced completion of a sympathetic nervous system cycle that the body, under chronic stress or trauma, may have been unable to complete on its own. Sauvagine also stimulates smooth muscle contraction of the colon and urinary bladder, and its CRF1 activity is relevant to mood, anxiety, depression, and addiction research.

Deltorphin and Dermorphin — Opioid Activity Unlike Anything Else

Deltorphins are 7-residue opioid peptides with the highest known binding affinity and selectivity for delta (δ) opioid receptors of any naturally occurring compound.⁸ Dermorphin acts at mu (µ) opioid receptors with an estimated analgesic potency 40 to 1,000 times greater than morphine, depending on the assay method.⁹ Neither is present in large quantities — deltorphin at roughly 53 micrograms per gate, dermorphin at trace levels — but their receptor affinity is extraordinary.

Delta opioid receptor activity has been studied for its role in neuroprotection, modulation of the gut-brain axis, and vagal nerve influence. Deltorphin II is currently being investigated as a potential intervention for ischemic injury (oxygen deprivation to tissues), with implications for cardiac and stroke research. These are areas of active scientific development, not settled therapeutic conclusions.

Dermaseptins — Antimicrobial Potential, With Important Caveats

The dermaseptin family are broad-spectrum antimicrobial peptides that destroy pathogens by physically disrupting their cell membranes — a mechanism distinct from antibiotics, and one that does not appear to generate resistance.¹⁰ In laboratory settings, dermaseptins from Phyllomedusa species have demonstrated activity against bacteria, fungi, yeasts, protozoa, HSV-1, and HIV-1.

The important caveat, stated directly by Thompson and Williams in the most comprehensive clinical review of Kambo's peptides to date: "the Kambô peptides are present only briefly in the body and in very low systemic concentrations, making it unclear if Kambô elicits acute or longer-term antimicrobial properties in vivo."³ This does not make dermaseptins unimportant — it means the clinical extrapolation from lab results to human outcomes has not yet been established. Honest engagement with this medicine requires holding both the potential and the uncertainty.

Not a Poison. Not a Detox. A Bioactive Conversation.

When the full pharmacological picture is visible, what emerges is not a cleansing ritual or a toxin purge. It is a highly coordinated, receptor-specific conversation between an evolved peptide cocktail and multiple human physiological systems simultaneously. The cardiovascular system opens. The GI tract empties and resets. The HPA axis fires and completes a stress cycle. Opioid receptors are engaged in ways that have no pharmaceutical parallel. The immune system receives downstream signals it may not have received in some time.

Holistika Center Retreats

At Holistika Center, this understanding is the foundation of how we work with Kambo. Not because the science replaces the traditional knowledge — it doesn't, and shouldn't — but because clarity about mechanism allows for better preparation, more appropriate screening, and more meaningful integration of what arises during the session.

The language we use to describe this medicine shapes the relationship people have with it before they ever sit in ceremony. Precise language is, in that sense, a form of respect.

Ritshi Zenati, Speaker & Life Coach

Founder at Holistika Center. 

Holistika Center holds Kambo ceremonies as part of multilingual plant medicine retreats across Barcelona, Málaga, Mallorca, Switzerland, Germany, and Norway. Learn more at www.holistika.center.

#Kambo #KamboMedicine #AmazonianMedicine #TraditionalMedicine #HealingJourney #NaturalHealing #SpiritualJourney #AncestralWisdom #HolisticHealth #BioactivePeptides #ScientificResearch #Ethnobotany #PhyllomedusaBicolor #Dermorphin #Dermaseptins #AlternativeMedicine #Herbalism #Pharmacology #FrogMedicine #Pachamama #Ayahuasca #PlantMedicine #MindBodySpirit #Consciousness #HolisticLiving #JungleMedicine #IndigenousCulture #Wellness #InnerEvolution #Ritual.

References

1. Calderon et al. (2011). Over 277 unique peptides characterized across Phyllomedusa genus. Cited in Nogueira et al. (2022), Frontiers in Pharmacology, 13:997318.

2. Thompson, C. & Williams, M.L. (2022). Review of the physiological effects of Phyllomedusa bicolor skin secretion peptides on humans receiving Kambô. SAGE Open Medicine. doi:10.1177/23978473221085746

3. Erspamer, V. et al. (1993). Pharmacological studies of 'sapo' from the frog Phyllomedusa bicolor skin. Toxicon, 31(9), 1099–1111.

4. Based on 10mg per gate estimate. Erspamer 1993; Thompson & Williams 2022.

5. Nogueira, T.A. et al. (2022). The Amazonian kambô frog Phyllomedusa bicolor: Current knowledge on biology, phylogeography, toxinology, ethnopharmacology and medical aspects. Frontiers in Pharmacology, 13:997318.

6. Anastasi, A. et al. (1969). Structure and pharmacological actions of phyllocaerulein. British Journal of Pharmacology, 37(1), 198–206.

7. Thompson & Williams, 2022, op. cit.

8. Erspamer, V. et al. (1989). Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites. PNAS, 86(13), 5188–5192.

9. Mignogna, G. et al. (1992). Identification and characterization of two dermorphins from skin extracts of the Amazonian frog Phyllomedusa bicolor. FEBS Letters, 302(2), 151–154.

10. Bartels, E.J.H. et al. (2019). Dermaseptins, multifunctional antimicrobial peptides: a review. Frontiers in Pharmacology, 10:1421.